Epidemiology and long-term prognosis of atrial fibrillation in rural African patients

• Main Authors: Dakaboué Germain Mandi, Joel Bamouni, Dangwé Temoua Naïbé, Rélwendé Aristide Yaméogo, Elisé Kaboré, Yibar Kambiré, Koudougou Jonas Kologo, Georges Rosario Christian Millogo, Nobila Valentin Yaméogo, Anna Thiam Tall, Patrice Zabsonré
• Format: Article
• Language: English
• Published: SpringerOpen 2019-09-01
• Series: The Egyptian Heart Journal
• Subjects: Atrial fibrillation; Epidemiology; Anticoagulation; Morbidity; Mortality; Africa
• Online Access: http://link.springer.com/article/10.1186/s43044-019-0005-3

Abstract Background Few studies have addressed the pattern of atrial fibrillation (AF) in rural Africa. The purpose of the study was to assess the epidemiology and long-term prognosis of AF in rural African patients in the Regional Hospital Center (RHC) of Tenkodogo, Burkina Faso. Results Overall, 107 of 1805 cardiac cases presented with AF (prevalence of 5.9%). Six patients were excluded. Mean age was 66.56 ± 14.92 years, and 53.47% were female. Hypertension was the most prevalent cardiovascular risk factor (59.41%). Congestive heart failure (HF) was reported in 85.15% of the study patients at presentation. Most of the study population presented with severe underlying heart disease (93.1%), and hypertensive heart disease was the most prevalent with 45.54% of the cases. The mean CHA2DS2VASc score in patients with non-valvular heart disease (n = 91) was 3.33 ± 1.25 (extremes 1–6) while the risk of bleeding was low (HAS-BLED score ≤ 1) in 82 patients (81.2%). Oral anticoagulation was prescribed in few cases (5.26%). During a follow-up period of 74.43 ± 23.94 weeks, acute HF and stroke occurred in respectively 43 and 6 patients. Forty-one patients (40.59%) died. The overall survival rate was 69% at 6-month and 59.4% at 1-year follow-up. Patients with idiopathic dilated cardiomyopathy were at higher risk of death than other patients (log-rank test = 11.88, p < 0.001) over time. Conclusion AF is not rare in rural African patients and is associated with an increased long-term risk of HF, stroke, and mortality.